Irritable Bowel Syndrome

Use of complementary and alternative medicine by pediatric patients with functional and organic gast
OBJECTIVES: Many pediatric patients use complementary and alternative medicine, especially when facing a chronic illness for which treatment options are limited.
PO Box 2500, 3430 EM Nieuwegein
Nieuwegein, The Netherlands
The Netherlands
Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potenti
The discovery of a novel class of peripheral tryptophan hydroxylase (TPH) inhibitors is described.
350 Carter Road
Princeton, NJ 08540
USA
[The efficacy of probiotics in gastrointestinal disease]
Probiotics are live microbial feed supplement which beneficially affects the host animals by improving its microbial balance.


Japan
Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatmen
Irritable bowel syndrome (IBS) is a chronic disorder characterized by abdominal pain, change in bowel habit, and bloating.

London, UK
UK
Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS). A double-blind, randomized
OBJECTIVE: To evaluate the role of the endogenous protein anti-secretory factor (ASF) on the symptoms, especially loose stools, in irritable bowel ayndrome (IBS).

Dalby, Sweden
Sweden
[The irritable syndrome--where do we stand?]
Given its high prevalence and the chronic course of disease, the Irritable Bowel Syndrome (IBS) represents an important clinical picture for general practioners.

Bern, Germany
Germany
[Nutritional Factors and Nutritional Therapy for Irritable Bowel Syndrome - What is Worthwhile?]
The prevalence of irritable bowel syndrome (IBS) has increased over the last 50 years in countries where a Western-style diet has been prominent or introduced and 20 - 65 % of patients with irritable bowel syndrome (IBS) attribute their symptoms to something in food that activates an abnormal response.

Frankfurt, Germany
Germany
Mind/Body psychological treatments for irritable bowel syndrome
Currently, the goal of treatment for those with irritable bowel syndrome (IBS) is to improve the quality of life through a reduction in symptoms.

Los Angeles, CA
USA
Rifaximin Treatment for Symptoms of Irritable Bowel Syndrome (March)
OBJECTIVE: To evaluate the role of rifaximin in the treatment of symptoms associated with irritable bowel syndrome (IBS).

Durham, NC
USA
Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome—a multice
Aim: To identify an appropriate dose of renzapride (a 5-HT(4) receptor full agonist/5-HT(3) receptor antagonist) to treat abdominal pain/discomfort in patients with IBS-C.

Soham, UK
UK